Trials / Withdrawn
WithdrawnNCT00432263
Treatment Of Adult Growth Hormone Deficiency After Traumatic Brain Injury.
Placebo-Controlled Trial On The Efficacy Of Growth Hormone Replacement Therapy In Patients With Growth Hormone Deficiency After Traumatic Brain Injury
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
To establish the effects of genotropin replacement in patients with severe growth hormone deficiency after traumatic brain injury on cognitive function.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Genotropin (PN-180,307) Somatropin |
Timeline
- Start date
- 2007-04-01
- First posted
- 2007-02-07
- Last updated
- 2015-04-22
Source: ClinicalTrials.gov record NCT00432263. Inclusion in this directory is not an endorsement.